Institute of Translational Medicine

The Institute of Translational Medicine (ITM) is a joint initiative between University Hospitals Birmingham NHS Foundation Trust, the University of Birmingham and Birmingham Children’s Hospital as part of Birmingham Health Partners (BHP).

The importance of Translational Medicine

Translational medicine is about moving new findings and knowledge from the laboratory setting into patient care. It involves using laboratory and diagnostic findings, patient-based clinical data and patient reported outcome and experience measures to drive improvements in treatment, offer personalised treatment options and reduce treatment side effects.

Birmingham is one of the few global cities with all the requirements to deliver this due to its unique health campus encompassing; the largest hospital in Europe, a high performing research university – The University of Birmingham, and its large and diverse six million strong patient cohort.


Institute of Translational Medicine

The ITM will serve as the engine to translate laboratory discovery into improved and increasingly personalised patient care. It will bring together patients, clinicians, trials and research expertise, with bioinformatics and personalised medicine at its core.  

As a central meeting point and working hub, it will allow clinicians, academics, patient groups and industry to develop productive collaborative networks. It will also facilitate the rapid assessment of cost-effective new drugs and medical devices, and the bespoke design of clinical trials will result in effective monitoring and robust interpretation of outcomes.

The ITM will have a particular focus on early phase clinical trials in the following disease areas:

  • Cancer – clinical academics studying and treating a broad range of cancers from blood cancers to solid tumours, will work together to share findings and increase understanding of the disease process and treatment pathways
  • Rare Disease – Birmingham’s diverse ethnic make-up means that we are well placed to study and treat a huge variety of rare diseases that are seen relatively infrequently elsewhere in the county
  • Chronic Disease– Specifically looking at auto-immune diseases such as Rheumatoid Arthritis that can have a debilitating impact on patients
  • Devices and diagnostics –Working in partnership with companies to trial new devices and diagnostic techniques
  • Acute Care – Birmingham is a world leading trauma centre and the Institute will build on this strength

Find out more 

Visit the Birmingham Health Partners website to find out more about the ITM and how you can get involved.